Antiplatelet Therapy in ACS and CABG Surgery: Focus on Timing, Safety,  Bleeding Risk, and Guidelines for Thienopyridines
Sunil V. Rao, MD

Applying Evidence to Patient Management: Integrating Bivalirudin into Practice Algorithms for ACD and STEMI
Harold L. Dauerman, MD, FACC

Focus on Oral Antiplatelet Therapy in ACS: The Upstream and Downstream Perspective
Charles Victor Pollack, Jr. M.S., MD, FACEP, FAAEM

Critical Challenges In ACS Management: The Emergency Medicine Perspective
Charles Victor Pollack, Jr. M.A., M.D., FACEP

Outcome-Effective Management of Acute Coronary Syndromes
Dr. Charles Pollack

Invasive Management of Acute Coronary Syndromes
Gregg Stone, MD, FACC

The Current and Future Role of Neuroimaging in Patients with Dementia
Steven G. Potkin, M.D.

Alzheimer's Disease: Multimodal Management in the Long-Term Care (LTC) Setting
Joseph L. Micca, MD

Alzheimer's Disease: Critical Challenges in Behavioral Management
Kevin Franklin Gray, M.D.

Alzheimer's Dementia - Diagnosis, Staging, and Outcome-Effective Drug Therapy—An Evidence-Based Perspective
Dr. Jeffrey L. Cummings

Optimizing Pharmacologic and Nonpharmacologic Management in The Assisted Living and Nursing Home Setting
Dr. Elaine R. Peskind

Screen and Intervene - Critical Challenges in Alzheimer's Dementia: A Geriatric Psychiatric Expert Outlines Optimal and Evidence-Based Management
Dr. George T. Grossberg

Landmark Advances in Minimal and Moderate Sedation - Focus on New Pharmacologic Agents for Colonoscopy Bronchoscopy , and Minor Surgical Procedures
T. J. Gan, MD

Year 2007 NIH Asthma Guidelines - The Mandate to Identify Allergic Triggers
Leonard Fromer, MD FAAFP

Current Therapies for Chemotherapy-Induced Nausea and Vomiting. Focus on Optimizing Symptoms, Quality of Life, and Antiemetic  Effects in the Immediate and Delayed Phase Following Chemotherapy
Lee S. Schwartzberg, MD FACP

Focus on 1,5 Anhydroglucitol (AG) for Monitoring and Clinical Management of Patients with Diabetes
Steven D. Wittlin, MD
 

The Science and Medicine of VTE Prophylaxis - Translating Landmark Trials and ACCP Guidelines into Best Hospital  Practice. Part 1: DTV Risk Assessment and Intervention Upon Hospital Admission
Samuel Z. Goldhaber, MD

The Science and Medicine of VTE Prophylaxis - Translating Landmark Trials and ACCP Guidelines into Best Hospital  Practice. Part 2: Dynamic DTV Risk Assessment During Hospital Admission
Samuel Z. Goldhaber, MD

The Science and Medicine of VTE Prophylaxis - Translating Landmark Trials and ACCP Guidelines into Best Hospital  Practice. Part 3: LMWH-based therapy in the Post-Hospitalization Phase
Samuel Z. Goldhaber, MD

Efficacy and Safety Advantages of Enoxaparin vs. Unfractionated Heparin For DVT Prophylaxis in Medical Patients - The PRINCE Trial
Dr. Fanz-Xaver Kleber

Diagnosis, Assessment, and Pharmacologic Management of a Challenging Syndrome. Focus on Pathophysiology and Emerging Therapies
Don L. Goldenberg, MD

Optimizing Management of FM. A Systematic Approach to Pharmacotherapy. Focus on Dual Reuptake (SNRI) Inhbition
Robert M. Bennett, MD, FRCP, FACP, MACR

Advances in Cardiovascular Medicine
Year 2007 Update - Focus on Cardioselective Beta Blockers for Heart Failure and Hypertension
Mark E. Dunlap, MD
 

Hypertension in African Americans
Kenneth A. Jamerson, MD

Innovations in Bea-Blocker Therapy for Hypertension
William H. Frishman, MD

Advances in Hypertension
Year 2007 Update - Focus on Cardioselective Beta Blockers
Michael A. Weber, M.D.

Diagnosis, Risk Assessment, and Long-Term Monitoring of Patients with Kidney Stones
Glenn M. Preminger, M.D.

Critical Challenges in MRSA Skin and Skin Structure Infections
Lena M. Napolitano, MD, FACS, FCCP, FCCM

MRSA Lung Infection: From the Community to the Hospital
Marin H. Kollef, M.D.

Focus on Staging, Enduring Remissions, and Poor Responders to Immune Modulating Therapy
Patricia Coyle, MD

Focus on Disease Classification Natural History,  Diagnostic Issues, Pivotal Trials, and Long-Term Outcomes
Jerry S. Wolinksy, MD

Optimizing Outcomes with Evidence-Based Approaches for Bisphosphonate Therapy. Focus on Fracture Reduction with Prolonged Dosing Intervals
Sol Epstein, MD

Optimizing Fracture Reduction in Osteoporosis. Focus on Annual Cumulative Exposure (ACE), Extended Dosing Intervals, and Osteoprotection 
Steven D. Harris, MD FACP

Optimizing Therapy for Osteoporosis: Aligning Specific Clinical Profiles with Evidence-Based Treatment Strategies for Osteoporosis
Felicia Cosman, MD

Landmark Clinical Advances in Osteoporosis: Focus on New Therapies for Optimizing Fracture Prevention
Felicia Cosman, MD

Screen and Intervene: Clinical Challenges in Osteoporosis Management. The Primary Care Perspective
Mone Zaidi, MD, PhD, FRCP

Focus on the Evolution of Clinical Efficacy of Bisphosphonates of Osteoporosis - Translating Science into Daily Practice
Mone Zaidi, MD, PhD, FRCP

Focus on Early, Evidence-Based Management of OAB. the Foundation Role of Muscarinic Receptor Antagonists
David R. Staskin, MD

Overactive Bladder: Clinical Challenges and Optimizing Patient Outcomes
Scott MacDiarmid MD

Focus on Early Treatment, Neuroprotection, and the Delayed Start  ADAGIO Trial
C. Warren Olanow, MD, FRCPC

The Foundation Role of MAO-B Inhibitors in Parkinson's Disease: Early Diagnosis, Combination Therapy and Approaches to Disease Modification
Lawrence W. Elmer, MD, PhD

The Role of Ionic, Low Osmolar Contrast Media (LOCM) for  Thrombosis Reduction in the Setting of PCI
Steven V. Manoukian, MD, FACC, FSCAI

Redefining the Outcome Equation for Percutaneous Coronary Intervention
A. Michael Lincoff, M.D.

Innovations in Bea-Blocker therapy for Hypertension
William H. Frishman, MD

Hypertension in African Americans
Kenneth A. Jamerson, MD